no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Antithrombotic Agents in Coronary Artery Disease
|
Cairns, John A. |
|
1995 |
108 |
4S |
p. 380S-400S nvt p. |
article |
2 |
Antithrombotic Therapy for Cerebrovascular Disorders
|
Sherman, David G. |
|
1995 |
108 |
4S |
p. 444S-456S nvt p. |
article |
3 |
Antithrombotic Therapy for Venous Thromboembolic Disease
|
Hyers, Thomas M. |
|
1995 |
108 |
4S |
p. 335S-351S nvt p. |
article |
4 |
Antithrombotic Therapy in Atrial Fibrillation
|
Laupacis, Andreas |
|
1995 |
108 |
4S |
p. 352S-359S nvt p. |
article |
5 |
Antithrombotic Therapy in Children
|
Michelson, Alan D. |
|
1995 |
108 |
4S |
p. 506S-522S nvt p. |
article |
6 |
Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty
|
Popma, Jeffrey J. |
|
1995 |
108 |
4S |
p. 486S-501S nvt p. |
article |
7 |
Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves
|
Stein, Paul D. |
|
1995 |
108 |
4S |
p. 371S-379S nvt p. |
article |
8 |
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
|
Stein, Paul D. |
|
1995 |
108 |
4S |
p. 424S-430S nvt p. |
article |
9 |
Antithrombotic Therapy in Peripheral Arterial Occlusive Disease
|
Clagett, G. Patrick |
|
1995 |
108 |
4S |
p. 431S-443S nvt p. |
article |
10 |
Antithrombotic Therapy in Valvular Heart Disease
|
Levine, Herbert J. |
|
1995 |
108 |
4S |
p. 360S-370S nvt p. |
article |
11 |
Aspirin and Other Platelet-Active Drugs
|
Hirsh, Jack |
|
1995 |
108 |
4S |
p. 247S-257S nvt p. |
article |
12 |
Clinical Recommendations Using Levels of Evidence for Antithrombotic Agents
|
Cook, Deborah J. |
|
1995 |
108 |
4S |
p. 227S-230S nvt p. |
article |
13 |
Coronary Thrombolysis
|
Cairns, John A. |
|
1995 |
108 |
4S |
p. 401S-423S nvt p. |
article |
14 |
Hemorrhagic Complications of Anticoagulant Treatment
|
Levine, Mark N. |
|
1995 |
108 |
4S |
p. 276S-290S nvt p. |
article |
15 |
Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism
|
Levine, Mark N. |
|
1995 |
108 |
4S |
p. 291S-301S nvt p. |
article |
16 |
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
|
Hirsh, Jack |
|
1995 |
108 |
4S |
p. 258S-275S nvt p. |
article |
17 |
Introduction
|
Dalen, James E. |
|
1995 |
108 |
4S |
p. 225S-226S nvt p. |
article |
18 |
Making Decisions About Antithrombotic Therapy in Heart Disease
|
Eckman, Mark H. |
|
1995 |
108 |
4S |
p. 457S-470S nvt p. |
article |
19 |
Medicolegal Implications of Consensus Statements
|
McIntyre, Kevin M. |
|
1995 |
108 |
4S |
p. 502S-505S nvt p. |
article |
20 |
New Antithrombotics
|
Weitz, Jeffrey I. |
|
1995 |
108 |
4S |
p. 471S-485S nvt p. |
article |
21 |
Oral Anticoagulants
|
Hirsh, Jack |
|
1995 |
108 |
4S |
p. 231S-246S nvt p. |
article |
22 |
Prevention of Venous Thromboembolism
|
Clagett, G. Patrick |
|
1995 |
108 |
4S |
p. 312S-334S nvt p. |
article |
23 |
Therapeutic Use of n-3 Fatty Acids for Vascular Disease and Thrombosis
|
Goodnight, Scott H. |
|
1995 |
108 |
4S |
p. 302S-304S nvt p. |
article |
24 |
Use of Antithrombotic Agents During Pregnancy
|
Ginsberg, Jeffrey S. |
|
1995 |
108 |
4S |
p. 305S-311S nvt p. |
article |